Today, Jan. 23, 2026, profit taking and fresh glioblastoma survival data weighed on a soaring biotech stock. ImmunityBio ( IBRX 12.13%), an immunity-focused biotech, closed Friday’s session at $6.45, …
Stock Market Today, Jan. 23: ImmunityBio Falls After Gaining Over 200% in a Month
view original post